A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1997
12/29/1997	EP0813524A1 Indole derivatives as eaa antagonists
12/29/1997	EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives
12/29/1997	EP0813423A1 Composition to ameliorate osteolysis and metastasis
12/29/1997	EP0813422A1 Compositions and methods for stimulating antibody class switching
12/29/1997	EP0813418A2 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase
12/29/1997	EP0813414A1 Combination of bisphosphonates and growth hormone secretagogues
12/29/1997	EP0813409A1 Treatment of cytokine growth factor caused disorders
12/29/1997	EP0719264B1 Imidazolone and oxazolone derivatives as dopamine antagonists
12/29/1997	EP0648120B1 Use of phosphonates for the treatment of osteoporosis
12/24/1997	WO1997048805A1 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF
12/24/1997	WO1997048803A1 Human protein kinase c inhibitor homolog
12/24/1997	WO1997048802A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG
12/24/1997	WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins
12/24/1997	WO1997048713A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b
12/24/1997	WO1997048699A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
12/24/1997	WO1997048697A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
12/24/1997	WO1997048682A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators
12/24/1997	WO1997048680A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use
12/24/1997	WO1997048672A2 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
12/24/1997	WO1997048400A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors
12/24/1997	WO1997048399A1 Certain phosphinyl derivatives useful as naaladase inhibitors
12/24/1997	WO1997048389A1 2-cyclopenten-1-one as an inducer of hsp70
12/24/1997	WO1997038699A3 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation
12/24/1997	WO1997036497A3 Cocoa extract compounds and methods for making and using the same
12/24/1997	CN1168695A Inhibitor of stem cell proliferation and uses thereof
12/24/1997	CN1168678A Method of treating diabetes mellitus using KGF
12/24/1997	CN1168672A 2,7-substituierte octahydro-1H-pyrido £1,2-A\| pyrazin derivate
12/24/1997	CN1168667A Pyridopyrimidones, quinolines and fused N-heretocycles as bradykinin antagonists
12/24/1997	CN1168634A Kit for osteoporosis treatment cycle
12/24/1997	CN1168633A Boronic ester and acid compounds, synthesis and uses
12/24/1997	CA2258919A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use
12/24/1997	CA2258589A1 Certain phosphinyl derivatives useful as naaladase inhibitors
12/24/1997	CA2258587A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors
12/24/1997	CA2258536A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators
12/24/1997	CA2258313A1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
12/24/1997	CA2258240A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
12/24/1997	CA2257855A1 Human thymosin .beta.15 gene, protein and uses thereof
12/24/1997	CA2257847A1 Polynucleotides from human fetal brain encoding secreted proteins
12/24/1997	CA2257528A1 Human protein kinase c inhibitor homolog
12/24/1997	CA2257361A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b
12/24/1997	CA2257130A1 Human camp-dependent protein kinase inhibitor homolog
12/23/1997	US5700922 PNA-DNA-PNA chimeric macromolecules
12/23/1997	US5700911 Bone morphogenetic protein -11 (BMP-11) compositions
12/23/1997	US5700909 For stimulating neural cell outgrowth
12/23/1997	US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors
12/23/1997	US5700827 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds
12/23/1997	US5700821 Inhibit cell proliferation
12/23/1997	US5700816 Antiarthritic agents
12/23/1997	US5700813 Treatment of thrombotic illness
12/23/1997	US5700812 Antispasmodic agent for cardiovascular disorder, antiserotonine agent
12/23/1997	US5700811 Potent inducers of terminal differentiation and method of use thereof
12/23/1997	US5700807 Endothelin receptor antagonists
12/23/1997	US5700806 Farnesyl protein transferase enzyme inhibitor, antitumor agents
12/23/1997	US5700801 Antiinflammatory agents, bone disorders
12/23/1997	US5700798 Methods for using benzoxazines for treating asthma
12/23/1997	US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines
12/23/1997	US5700675 Protein kinase required for Ras signal transduction
12/23/1997	US5700459 Polybase and polyacid, one of which is a polymer, active material comprising antiinflammatory agent, antibiotic, enzyme inhibitor
12/23/1997	CA2126972C Styrene derivative and salts thereof
12/23/1997	CA2008391C 1,2-cyclohexylaminoaryl amides useful as analgesic agents
12/20/1997	CA2208174A1 Squalene synthetase inhibitors
12/19/1997	CA2208136A1 Inhibition of abnormal accumulation of extracellular matrices
12/18/1997	WO1997047744A2 T-cell selective interleukin-4 agonists
12/18/1997	WO1997047619A1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
12/18/1997	WO1997047618A1 Substituted imidazoles having cytokine inhibitory activity
12/18/1997	WO1997047604A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
12/18/1997	WO1997047602A1 Tricyclic amine derivatives
12/18/1997	WO1997047599A1 Succinamide derivatives useful as tnf- and/or mmp inhibitors
12/18/1997	WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997	WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997	WO1997047315A1 Method of stimulating cilia
12/18/1997	WO1997047308A1 Eutrophic drug compositions based on transferrin glycans
12/18/1997	WO1997047304A1 Fast-dissolving galanthamine hydrobromide tablet
12/18/1997	WO1997047302A1 Inhibition of serotonin reuptake
12/18/1997	WO1997047298A1 Therapeutic treatment for cardiovascular diseases
12/18/1997	WO1997047296A2 Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies
12/18/1997	WO1997035982A3 Monocyte chemotactic protein-5 materials and methods
12/18/1997	WO1997035015A3 Tyrosine-phosphatase-related protein
12/18/1997	CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997	CA2257693A1 Therapeutic treatment for cardiovascular diseases
12/18/1997	CA2256649A1 Inhibition of serotonin reuptake
12/18/1997	CA2256459A1 T-cell selective interleukin-4 agonists
12/18/1997	CA2208581A1 Substituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions
12/18/1997	CA2207886A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
12/17/1997	EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family
12/17/1997	EP0812844A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
12/17/1997	EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists
12/17/1997	EP0812826A1 1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake
12/17/1997	EP0812362A1 A plasmid for expressing modified recombinant proteins in a bacterial system
12/17/1997	EP0812360A1 Human geranylgeranyl pyrophosphate synthetase
12/17/1997	EP0812356A1 Prostate-specific membrane antigen and uses thereof
12/17/1997	EP0812330A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
12/17/1997	EP0812327A1 Protein phosphatase inhibitor
12/17/1997	EP0812319A1 2-arylbenzazole compounds
12/17/1997	EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors
12/17/1997	EP0812203A1 Inhibitors of geranylgeranyl-protein transferase
12/17/1997	EP0812199A1 Sphingosine, methylsphingosine and apoptosis
12/17/1997	EP0812198A1 Storage-stable prostaglandin compositions
12/17/1997	EP0812190A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
12/17/1997	EP0812185A2 Use of angiogenesis suppressors for inhibiting hair growth

1 ... 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 ... 1564